Lifevantage Corp
Nasdaq: LFVNPharmaceutical Preparations · Entity-resolved by Clous
Key financials
Market
Short interest & fails
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
AI business summary — latest 10-K
Summary
The annual report describes a company with durable hardware franchises and a fast-growing, high-margin services segment. Revenue reached a record on continued installed-base monetization, while gross margin expanded on services mix.
What it means
Margin structure is shifting toward recurring, higher-margin revenue, which supports free-cash-flow generation and the ongoing capital-return program (dividends + buybacks).
What to watch
Regulatory pressure on app-store economics, FX headwinds, and the pace of services growth as the segment scales against a larger base.
Generated from public filings · not investment advice
| Concept | FY2022-06-30 | FY2023-06-30 | FY2024-06-30 | FY2025-06-30 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $206.36M | $213.4M | $200.16M | $228.53M | +14.2% | 100% |
| Net Income | $3.12M | $2.54M | $2.94M | $9.81M | +233.8% | 4% |
| Total Assets | $70.71M | $66.12M | $60.3M | $71.96M | +19.3% | 31% |
| Equity | $31.52M | $34.65M | $25.99M | $34.64M | +33.3% | 15% |
| Operating Cash Flow | $7.96M | $6.83M | $12.2M | $11.88M | -2.6% | 5% |
| Shares Outstanding | — | — | — | 12.69M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0000849146